Electrical or pharmacologic cardioversion for atrial fibrillation in the ED?

Meaghan MacKenzie^{1

2}, Dana Stewart^{3

4}, Chris Hall⁴

Affiliations

¹ University of Calgary, Calgary, AB, Canada. Meaghan.mackenzie2@ucalgary.ca.
² Department of Emergency Medicine, Room C231, Foothills Medical Centre, University of Calgary, 1403-29 Street NW, Calgary, AB, T2N 2T9, Canada. Meaghan.mackenzie2@ucalgary.ca.
³ University of Calgary, Calgary, AB, Canada.
⁴ Department of Emergency Medicine, Room C231, Foothills Medical Centre, University of Calgary, 1403-29 Street NW, Calgary, AB, T2N 2T9, Canada.

PMID: 33683610
DOI: 10.1007/s43678-020-00019-1

Editorial

Electrical or pharmacologic cardioversion for atrial fibrillation in the ED?

Meaghan MacKenzie et al. CJEM. 2021 Jan.

. 2021 Jan;23(1):32-33.

doi: 10.1007/s43678-020-00019-1. Epub 2020 Dec 10.

Authors

Meaghan MacKenzie^{1

2}, Dana Stewart^{3

4}, Chris Hall⁴

Affiliations

¹ University of Calgary, Calgary, AB, Canada. Meaghan.mackenzie2@ucalgary.ca.
² Department of Emergency Medicine, Room C231, Foothills Medical Centre, University of Calgary, 1403-29 Street NW, Calgary, AB, T2N 2T9, Canada. Meaghan.mackenzie2@ucalgary.ca.
³ University of Calgary, Calgary, AB, Canada.
⁴ Department of Emergency Medicine, Room C231, Foothills Medical Centre, University of Calgary, 1403-29 Street NW, Calgary, AB, T2N 2T9, Canada.

PMID: 33683610
DOI: 10.1007/s43678-020-00019-1

No abstract available

Keywords: Atrial fibrillation; Cardioversion; Procainamide.

PubMed Disclaimer

Comment on

Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial.
Stiell IG, Sivilotti MLA, Taljaard M, Birnie D, Vadeboncoeur A, Hohl CM, McRae AD, Rowe BH, Brison RJ, Thiruganasambandamoorthy V, Macle L, Borgundvaag B, Morris J, Mercier E, Clement CM, Brinkhurst J, Sheehan C, Brown E, Nemnom MJ, Wells GA, Perry JJ. Stiell IG, et al. Lancet. 2020 Feb 1;395(10221):339-349. doi: 10.1016/S0140-6736(19)32994-0. Lancet. 2020. PMID: 32007169 Clinical Trial.

References

1. Scheuermeyer FX, et al. A multicenter randomized trial to evaluate a chemical-first or electrical-first cardioversion strategy for patients with uncomplicated acute atrial fibrillation. AcadEmerg Med. 2019;26(9):969–81.
1. Stiell IG, et al. CAEP acute atrial fibrillation/flutter best practices checklist. Can J Emerg Med. 2018;20(3):334–42. - DOI
1. Constantino G, Solbiati M. Atrial fibrillation cardioversion in the emergency department. The Lancet. 2020;395:314–314. - DOI

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Springer
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Electrical or pharmacologic cardioversion for atrial fibrillation in the ED?

Affiliations

Electrical or pharmacologic cardioversion for atrial fibrillation in the ED?

Authors

Affiliations

Comment on

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical